State Supreme Court Rejects Challenge, Clearing Way for Stem Cell Bond Initiative
By Joyce E. Cutler,
Bureau of National Affairs
| 05. 17. 2007
The California Supreme Court refused May 16 to consider a constitutional challenge to the state stem cell initiative, clearing the way for $3 billion in bonds to be sold to fund stem cell research (People's Advocate and National Tax Limitation Foundation v. Independent Citizens Oversight Committee, Cal., No. S151574, review denied, 5/16/07).
Justices at their weekly meeting declined to review the appeal brought by opponents of California's Proposition 71, a November 2004 initiative authorizing an annual pool of $300 million to further stem cell and other medical research over a decade.
Justice Joyce Kennard voted to grant review of the decision by the California Court of Appeal, First District, upholding the initiative, according to the court docket.
A unanimous panel of the appeals court ruled last February, “we have no hesitation in concluding, in the exercise of 'our solemn duty to jealously guard the precious initiative power,’ that Proposition 71 suffers from no constitutional or other legal infirmity” (California Family Bioethics Council v. Independent Citizens' Oversight Committee, Cal. Ct. App., No. A114195; People's Advocate v. Independent Citizens' Oversight Committee, Cal...
Related Articles
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Ed Pilkington, The Guardian | 06.12.2026
Desperate US parents paying up to $20,000 a session for a procedure scientists say could be bogus
Autistic children as young as 18 months old are being injected with human stem cells derived from umbilical cords in unapproved, unproven and...
By Tobi Thomas, The Guardian | 06.10.2026
The UK’s stem cell transplant system is potentially putting the lives of blood cancer patients at risk as a result of inadequate infrastructure and a lack of long-term planning, a parliamentary report has found.
A hematopoietic stem cell transplant, often...